These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2306517)

  • 1. Human platelet osteonectin: release, surface expression, and partial characterization.
    Kelm RJ; Mann KG
    Blood; 1990 Mar; 75(5):1105-13. PubMed ID: 2306517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation.
    Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C
    J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets.
    Hsu-Lin S; Berman CL; Furie BC; August D; Furie B
    J Biol Chem; 1984 Jul; 259(14):9121-6. PubMed ID: 6746643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelets contain and secrete osteonectin, a major protein of mineralized bone.
    Stenner DD; Tracy RP; Riggs BL; Mann KG
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6892-6. PubMed ID: 3489235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intertissular variations in osteonectin: a monoclonal antibody directed to bone osteonectin shows reduced affinity for platelet osteonectin.
    Malaval L; Darbouret B; Preaudat C; Jolu JP; Delmas PD
    J Bone Miner Res; 1991 Apr; 6(4):315-23. PubMed ID: 1713400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous platelet fibrinogen surface expression on activated platelets.
    Gralnick HR; Williams S; McKeown L; Connaghan G; Shafer B; Hansmann K; Vail M; Fenton J
    J Lab Clin Med; 1991 Dec; 118(6):604-13. PubMed ID: 1744509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex formation of human thrombospondin with osteonectin.
    Clezardin P; Malaval L; Ehrensperger AS; Delmas PD; Dechavanne M; McGregor JL
    Eur J Biochem; 1988 Aug; 175(2):275-84. PubMed ID: 3402455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted modular calcium-binding protein 1 binds and activates thrombin to account for platelet hyperreactivity in diabetes.
    Delgado Lagos F; Elgheznawy A; Kyselova A; Meyer Zu Heringdorf D; Ratiu C; Randriamboavonjy V; Mann AW; Fisslthaler B; Siragusa M; Fleming I
    Blood; 2021 Mar; 137(12):1641-1651. PubMed ID: 33529332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and structure of activated-platelet protein-1, a protein with RNA-binding domain motifs that is expressed by activated platelets.
    Houng AK; Maggini L; Clement CY; Reed GL
    Eur J Biochem; 1997 Jan; 243(1-2):209-18. PubMed ID: 9030741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human osteoblast and megakaryocyte-derived osteonectin (SPARC).
    Kelm RJ; Hair GA; Mann KG; Grant BW
    Blood; 1992 Dec; 80(12):3112-9. PubMed ID: 1467517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A member of the selectin family (GMP-140/PADGEM) is expressed on thrombin-stimulated rat platelets in vitro.
    Winocour PD; Chignier E; Parmentier S; McGregor JL
    Comp Biochem Physiol Comp Physiol; 1992 Jun; 102(2):265-71. PubMed ID: 1380412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of two monoclonal antibodies to the central portion of human osteonectin.
    Villarreal XC; Malaval L; Mann KG; Delmas P; Long GL
    Calcif Tissue Int; 1991 Feb; 48(2):138-41. PubMed ID: 1707335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of ligand-occupied alpha IIb beta 3 in resting and activated human platelets determined by expression of a novel class of ligand-induced binding site recognized by monoclonal antibody AP6.
    Nurden P; Humbert M; Piotrowicz RS; Bihour C; Poujol C; Nurden AT; Kunicki TJ
    Blood; 1996 Aug; 88(3):887-99. PubMed ID: 8704246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against porcine platelet membrane glycoproteins Ib and IIb/IIIa.
    Takami H; Nichols WL; Kaese SE; Miller RS; Katzmann JA; Bowie EJ
    Blood; 1988 Nov; 72(5):1740-7. PubMed ID: 3140912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets contribute to circulating levels of bone sialoprotein in human.
    Chenu C; Delmas PD
    J Bone Miner Res; 1992 Jan; 7(1):47-54. PubMed ID: 1549958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological screening of SPARC/Osteonectin in nonmineralized tissues.
    Maillard C; Malaval L; Delmas PD
    Bone; 1992; 13(3):257-64. PubMed ID: 1637573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.
    Dubernard V; Legrand C
    J Lab Clin Med; 1991 Nov; 118(5):446-57. PubMed ID: 1940585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The collagen binding specificity of bone and platelet osteonectin is related to differences in glycosylation.
    Kelm RJ; Mann KG
    J Biol Chem; 1991 May; 266(15):9632-9. PubMed ID: 2033056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane expression of platelet calpain.
    Schmaier AH; Bradford HN; Lundberg D; Farber A; Colman RW
    Blood; 1990 Mar; 75(6):1273-81. PubMed ID: 2310827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation.
    Legrand C; Thibert V; Dubernard V; Bégault B; Lawler J
    Blood; 1992 Apr; 79(8):1995-2003. PubMed ID: 1562725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.